Maze Therapeutics stockMAZE
Maze Therapeutics trades at $32.53, 39.4% below its 52-week high (Mar 16, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. −21.5% year to date, +7.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for MAZE — after you log in
Open the terminalFrequently asked questions about Maze Therapeutics
What is the Maze Therapeutics stock price?
At the close on Nov 5, 2026: $32.53 (−2.55% on the day). 52-week high: $53.65 on Mar 16, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Maze Therapeutics report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed +1% year over year, revenue 0%.
Does Maze Therapeutics pay dividends?
No, Maze Therapeutics does not pay dividends.
Where does Maze Therapeutics trade and how to buy it?
Ticker MAZE, exchange Nasdaq, listed since 2025. You can buy it through a broker with access to US exchanges.
Should I buy Maze Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for MAZE are in the terminal after you log in.